7 results
DPP4 Inhibitors - Normal and Renal Dosing

Increase Incretins (GLP-I & GIP) -> Stimulates Insulin, Inhibits Glucagon
Normal and Renal Dosing ... thing about this drug ... This drug class ... #Pharmacology # ... Management #Diabetes
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
-1 Agonist Dosing ... to remain stable ... empagliflozin and DPP4 ... #semaglutide #Diabetes ... #Pharmacology #
GLP-1 Agonists

Adlyxin (Lixisenatide) Daily
Bydureon (Exenatide ER) Weekly 
Ozempic (Semaglutide) Weekly 
Trulicity (Dulaglutide) Weekly 
Victoza (Liraglutide) Daily
Common side effects ... There is an ORAL ... very similar to DPP4s ... GLP1 #Agonists #Pharmacology ... #Dosing #Diabetes
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
five effective oral ... If needed or if oral ... Tuberculosis #MDRTB #management ... antimicrobials #regimens #pharmacology ... #dosing #idsa #
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
Signs of congestion ... transitioning to oral ... differential #algorithm #management ... cardiology #treatment #table ... icu #clinical #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Please refer to the table ... dosing recommendations ... Guidelines for dosing ... Prevention #Treatment #management ... infections #HIVAIDS #pharmacology
Overview of antifungal agents benefits, weaknesses, and adverse effects in the treatment of Coccidioidomycosis.
Fluconazole - Low
weaknesses, and adverse effects ... • Therapeutic drug ... #valleyfever #management ... antifungals #comparison #table ... #pharmacology